CSPG4 (chondroitin sulfate proteoglycan 4)

2003-02-01  

Identity

HGNC
LOCATION
15q24.2
LOCUSID
ALIAS
CSPG4A,HMW-MAA,MCSP,MCSPG,MEL-CSPG,MSK16,NG2
FUSION GENES

Other Information

Locus ID:

NCBI: 1464
MIM: 601172
HGNC: 2466
Ensembl: ENSG00000173546

Variants:

dbSNP: 1464
ClinVar: 1464
TCGA: ENSG00000173546
COSMIC: CSPG4

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000173546ENST00000308508Q6UVK1

Expression (GTEx)

0
50
100
150
200
250

Pathways

PathwaySourceExternal ID
DiseaseREACTOMER-HSA-1643685
Diseases of glycosylationREACTOMER-HSA-3781865
Diseases associated with glycosaminoglycan metabolismREACTOMER-HSA-3560782
Defective B4GALT7 causes EDS, progeroid typeREACTOMER-HSA-3560783
Defective B3GAT3 causes JDSSDHDREACTOMER-HSA-3560801
Defective CHSY1 causes TPBSREACTOMER-HSA-3595177
Defective CHST3 causes SEDCJDREACTOMER-HSA-3595172
Defective CHST14 causes EDS, musculocontractural typeREACTOMER-HSA-3595174
MetabolismREACTOMER-HSA-1430728
Metabolism of carbohydratesREACTOMER-HSA-71387
Glycosaminoglycan metabolismREACTOMER-HSA-1630316
Heparan sulfate/heparin (HS-GAG) metabolismREACTOMER-HSA-1638091
A tetrasaccharide linker sequence is required for GAG synthesisREACTOMER-HSA-1971475
Chondroitin sulfate/dermatan sulfate metabolismREACTOMER-HSA-1793185
Chondroitin sulfate biosynthesisREACTOMER-HSA-2022870
Dermatan sulfate biosynthesisREACTOMER-HSA-2022923
CS/DS degradationREACTOMER-HSA-2024101
Defective B3GALT6 causes EDSP2 and SEMDJL1REACTOMER-HSA-4420332

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
383389022024Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer.0
383389022024Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer.0
366345192023Trophoblast-specific knockdown of CSPG4 expression causes pregnancy complications with poor placentation in mice.0
366746932023Neuron-Glial Antigen 2 Participates in Liver Fibrosis via Regulating the Differentiation of Bone Marrow Mesenchymal Stem Cell to Myofibroblast.1
369723082023Discovery of Hippo signaling as a regulator of CSPG4 expression and as a therapeutic target for Clostridioides difficile disease.2
371541952023Disrupting mechanical homeostasis promotes matrix metalloproteinase-13 mediated processing of neuron glial antigen 2 in mandibular condylar cartilage.2
366345192023Trophoblast-specific knockdown of CSPG4 expression causes pregnancy complications with poor placentation in mice.0
366746932023Neuron-Glial Antigen 2 Participates in Liver Fibrosis via Regulating the Differentiation of Bone Marrow Mesenchymal Stem Cell to Myofibroblast.1
369723082023Discovery of Hippo signaling as a regulator of CSPG4 expression and as a therapeutic target for Clostridioides difficile disease.2
371541952023Disrupting mechanical homeostasis promotes matrix metalloproteinase-13 mediated processing of neuron glial antigen 2 in mandibular condylar cartilage.2
362211192022CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response.3
362211192022CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response.3
336497902021Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF.0
337276402021NG2/CSPG4, CD146/MCAM and VAP1/AOC3 are regulated by myocardin-related transcription factors in smooth muscle cells.6
340781232021CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.9

Citation

Dessen P

CSPG4 (chondroitin sulfate proteoglycan 4)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/40174/cspg4-(chondroitin-sulfate-proteoglycan-4)